APA (7th ed.) Citation

FA, d. G., TJA, D., JK, D., S, B., M, B., RAL, d. G., . . . JSP, V. (2024). Clinical characteristics and survival outcomes of patients with primary central nervous system lymphoma treated with high-dose methotrexate-based polychemotherapy and consolidation therapies. European journal of cancer (Oxford, England : 1990), 213, 115068. https://doi.org/10.1016/j.ejca.2024.115068

Chicago Style (17th ed.) Citation

FA, de Groot, et al. "Clinical Characteristics and Survival Outcomes of Patients with Primary Central Nervous System Lymphoma Treated with High-dose Methotrexate-based Polychemotherapy and Consolidation Therapies." European Journal of Cancer (Oxford, England : 1990) 213 (2024): 115068. https://doi.org/10.1016/j.ejca.2024.115068.

MLA (9th ed.) Citation

FA, de Groot, et al. "Clinical Characteristics and Survival Outcomes of Patients with Primary Central Nervous System Lymphoma Treated with High-dose Methotrexate-based Polychemotherapy and Consolidation Therapies." European Journal of Cancer (Oxford, England : 1990), vol. 213, 2024, p. 115068, https://doi.org/10.1016/j.ejca.2024.115068.